127 related articles for article (PubMed ID: 38213210)
1. DNA Marker in Stool Led to a Second High-Quality Colonoscopy Within Three Months and Removal of an Undetected High-Risk Polyp.
Franck S; Eidens M; Fuhrländer J; Ogreid D
Clin Lab; 2024 Jan; 70(1):. PubMed ID: 38213210
[TBL] [Abstract][Full Text] [Related]
2. Early Detection of Colorectal Cancer: a Multi-Center Pre-Clinical Case Cohort Study for Validation of a Combined DNA Stool Test.
Dollinger MM; Behl S; Fleig WE
Clin Lab; 2018 Oct; 64(10):1719-1730. PubMed ID: 30336540
[TBL] [Abstract][Full Text] [Related]
3. Retrospective Review of Multitarget Stool DNA as a Screening Test for Colorectal Cancer.
Kleinschmidt TK; Clements A; Parker MA; Scarcliff SD
Am Surg; 2023 Apr; 89(4):603-606. PubMed ID: 34278822
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Patients with an Apparent False Positive Stool DNA Test: The Role of Repeat Stool DNA Testing.
Cooper GS; Markowitz SD; Chen Z; Tuck M; Willis JE; Berger BM; Brenner DE; Li L
Dig Dis Sci; 2018 Jun; 63(6):1449-1453. PubMed ID: 29516325
[TBL] [Abstract][Full Text] [Related]
5. Multitarget stool DNA testing for colorectal-cancer screening.
Imperiale TF; Ransohoff DF; Itzkowitz SH; Levin TR; Lavin P; Lidgard GP; Ahlquist DA; Berger BM
N Engl J Med; 2014 Apr; 370(14):1287-97. PubMed ID: 24645800
[TBL] [Abstract][Full Text] [Related]
6. miRNA as markers for the diagnostic screening of colon cancer.
Ahmed FE
Expert Rev Anticancer Ther; 2014 Apr; 14(4):463-85. PubMed ID: 24580550
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial.
Kim CW; Kim H; Kim HR; Kye BH; Kim HJ; Min BS; Oh TJ; An S; Lee SH
BMC Gastroenterol; 2021 Apr; 21(1):173. PubMed ID: 33858326
[TBL] [Abstract][Full Text] [Related]
8. Multitarget stool DNA testing for the prevention of colon cancer: outcomes in a large integrated healthcare system.
Vakil N; Ciezki K; Huq N; Singh M
Gastrointest Endosc; 2020 Aug; 92(2):334-341. PubMed ID: 31904379
[TBL] [Abstract][Full Text] [Related]
9. Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study.
Wang J; Liu S; Wang H; Zheng L; Zhou C; Li G; Huang R; Wang H; Li C; Fan X; Fu X; Wang X; Guo H; Guan J; Sun Y; Song X; Li Z; Mu D; Sun J; Liu X; Qi Y; Niu F; Chen C; Wu X; Wang X; Song X; Zou H
Clin Epigenetics; 2020 Oct; 12(1):162. PubMed ID: 33126908
[TBL] [Abstract][Full Text] [Related]
10. Novel multiplex stool-based assay for the detection of early-stage colon cancer in a Chinese population.
Jiang HH; Xing SW; Tang X; Chen Y; Lin K; He LW; Lin MB; Tang EJ
World J Gastroenterol; 2022 Jun; 28(24):2705-2732. PubMed ID: 35979157
[TBL] [Abstract][Full Text] [Related]
11. Early Detection of a Colorectal Carcinoma in an Asymptomatic Patient Using a Combined DNA Stool Test.
Amani A; Weber MM; Marko C
Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532101
[TBL] [Abstract][Full Text] [Related]
12. Stool DNA testing for early detection of colorectal cancer: systematic review using the HTA Core Model
Stürzlinger H; Conrads-Frank A; Eisenmann A; Invansits S; Jahn B; Janzic A; Jelenc M; Kostnapfel T; Mencej Bedrac S; Mühlberger N; Siebert U; Sroczynski G;
Ger Med Sci; 2023; 21():Doc06. PubMed ID: 37426885
[TBL] [Abstract][Full Text] [Related]
13. Detecting colorectal cancer in stool with the use of multiple genetic targets.
Dong SM; Traverso G; Johnson C; Geng L; Favis R; Boynton K; Hibi K; Goodman SN; D'Allessio M; Paty P; Hamilton SR; Sidransky D; Barany F; Levin B; Shuber A; Kinzler KW; Vogelstein B; Jen J
J Natl Cancer Inst; 2001 Jun; 93(11):858-65. PubMed ID: 11390535
[TBL] [Abstract][Full Text] [Related]
14. KRAS mutations and M2PK upregulation in stool samples from individuals with positive fecal occult blood tests screened for colorectal cancer.
Battaglia P; Baritono E; Remo A; Vendraminelli R; Conti A
Tumori; 2014; 100(2):122-7. PubMed ID: 24852854
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer following negative colonoscopy: is 5-year screening the correct interval to recommend?
Nakao SK; Fassler S; Sucandy I; Kim S; Zebley DM
Surg Endosc; 2013 Mar; 27(3):768-73. PubMed ID: 23052520
[TBL] [Abstract][Full Text] [Related]
16. Colonoscopy after a Positive Stool-based Test for Colon Cancer Screening: Moving Toward a Better Understanding of What to Expect.
Krigel A; Wan DW
Cancer Prev Res (Phila); 2022 Jul; 15(7):417-418. PubMed ID: 35788831
[TBL] [Abstract][Full Text] [Related]
17. Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer).
Stoffel EM; Turgeon DK; Stockwell DH; Zhao L; Normolle DP; Tuck MK; Bresalier RS; Marcon NE; Baron JA; Ruffin MT; Brenner DE; Syngal S;
Cancer Prev Res (Phila); 2008 Nov; 1(6):470-5. PubMed ID: 19138994
[TBL] [Abstract][Full Text] [Related]
18. Alaska Native Patient and Provider Perspectives on the Multitarget Stool DNA Test Compared With Colonoscopy for Colorectal Cancer Screening.
Redwood DG; Blake ID; Provost EM; Kisiel JB; Sacco FD; Ahlquist DA
J Prim Care Community Health; 2019; 10():2150132719884295. PubMed ID: 31646933
[No Abstract] [Full Text] [Related]
19. DNA methylation biomarkers of stool and blood for early detection of colon cancer.
Hong L; Ahuja N
Genet Test Mol Biomarkers; 2013 May; 17(5):401-6. PubMed ID: 23406208
[TBL] [Abstract][Full Text] [Related]
20. Multi-target stool DNA test in the surveillance of inflammatory bowel disease: a cross-sectional cohort study.
Klepp P; Kisiel JB; Småstuen MC; Røseth A; Andersen SN; Vatn MH; Ahlquist DA; Moum BA; Brackmann S
Scand J Gastroenterol; 2018 Mar; 53(3):273-278. PubMed ID: 29313389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
